EW Filing
144Filing Date: Jul 30, 2026
Edwards Lifesciences Corp (EW) · Proposed Sale (Form 144) SEC Filing
Insider Proposed Sale Notice
descriptionView SEC Filing
ACC: 0001921094-26-000777open_in_new
Sale Plan
Ullem Scott B.
Former Affiliate·Edwards Lifesciences Corp (EW)
Proposed
CommonNYSE
Shares50.00K
Est. DateJul 30
Market Value$4.63M
BrokerCharles Schwab & Co., Inc.
AcquisitionRSU / PSU - See Remarks · EDWARDS LIFESCIENCES CORPORATION
Acquired DateFeb 20, 2018
Amount Acquired50.00K
% Outstanding0.0087%
Exercise / Payment Details
Paid: Feb 20, 2018Method: Equity Compensation
Sales Past 3 Months Total $5.56M · 64.15K sh. expand_more
May
29
$5.56M
64.15K sh.
Signature & Compliance expand_more
Notice DateJul 30, 2026
Signature SCOTT B ULLEM TTEE
Issuer Info expand_more
CompanyEdwards Lifesciences Corp
CIK0001099800
SEC File No.001-15525
Phone9492502500
AddressONE EDWARDS WAY, IRVINE, CA 92614